Table: Phoenixbio -Q1 group results

PhoenixBio

14/08/2026 07:33

    Aug 14 (Reuters)- 
             Phoenixbio Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2026        Jun 30, 2025     Mar 31, 2027 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            258 mln             400 mln           1.61     
                 (-35.3 pct)         (-10.9 pct)      (+2.9 pct)  
  Operating      loss 93 mln           23 mln           85 mln    
                                    (+306.4 pct)      (+3.7 pct)  
  Recurring      loss 89 mln           20 mln           87 mln    
                                     (-17.9 pct)      (-33.5 pct) 
  Net            loss 91 mln           19 mln           76 mln    
                                     (-17.1 pct)      (-38.6 pct) 
  EPS          loss 22.38 yen         4.74 yen         18.90 yen  
  Ann Div                                NIL              NIL     
  -Q2 div                                NIL              NIL     
  -Q4 div                                NIL              NIL     
  
  NOTE - Phoenixbio Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T